Publications Office of the EU
France-Colmar: Medicinal products for the blood, blood-forming organs and the cardiovascular system - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

France-Colmar: Medicinal products for the blood, blood-forming organs and the cardiovascular system

  • Awarded
    28/02/2014
  • Today
    18/09/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Not available
Place of performance
NUTS code: FRF12 Haut-Rhin
Location of buyer
NUTS code: Not available
Business sector (Main CPV)
33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system
Total estimated contract value (excluding VAT)
82,500.00
Total final contract value (excluding VAT)
Not available
Tender reference number
Not available
Description

Contract with order forms.

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
Not available
Place of performance
Award method
Not specified
Estimated value
82,500.00
Final contracted value
Not available
Award of contract
Official name: Astellas Pharma
Postal address: 114 rue Victor Hugo
Town: Levallois-Perret
Postal code: 92686
Country: FRA
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.